Normally, DNA is transcribed, or copied, to RNA and then translated to protein. Reverse transcriptase copies RNA back to DNA. Think of it as a car moving down a one-way street. Normally traffic only moves in one direction. But then, someone from out of town is driving the opposite way! Reverse transcriptase drives the opposite way in molecular processes in cells, converting RNA back to DNA.
In the last several years, global market of Reverse Transcriptase developed smoothly, with an average growth rate of 4.6 %. In 2016, global revenue of Reverse Transcriptase is nearly 260 million USD; the actual production is about 570 liter.
The classification of Reverse Transcriptase includes MMLV Reverse Transcriptase and AMV Reverse Transcriptase; Moloney Murine Leukemia Virus (MMLV) Reverse Transcriptase is an RNA-directed DNA polymerase. This enzyme can synthesize a complementary DNA strand initiating from a primer using either RNA (cDNA synthesis) or single-stranded DNA as a template. And the sales proportion of MMLV Reverse Transcriptase in 2016 is about 80.9%.
Reverse Transcriptase can be used for PCR, Sequencing and Cloning, PCR was the largest application segment in 2016, and the proportion is about 59.4%. The application used in cloning with the fastest growth rate.
The global Reverse Transcriptase market is valued at 280 million US$ in 2018 and will reach 360 million US$ by the end of 2025, growing at a CAGR of 3.8% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Reverse Transcriptase market based on company, product type, end user and key regions.

This report studies the global market size of Reverse Transcriptase in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Reverse Transcriptase in these regions.
This research report categorizes the global Reverse Transcriptase market by top players/brands, region, type and end user. This report also studies the global Reverse Transcriptase market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Thermo Fisher
Promega
Roche
Bio-Rad
Takara Bio
Agilent
Qiagen
Fapon Biotech
Toyobo
Vazyme
New England Biolabs

Market size by Product
MMLV Reverse Transcriptase
AMV Reverse Transcriptase
Market size by End User
PCR
Sequencing
Cloning

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Reverse Transcriptase market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Reverse Transcriptase market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Reverse Transcriptase companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Reverse Transcriptase submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Reverse Transcriptase are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (L). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Reverse Transcriptase market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.